Add to ORKGThe reasonable timing of the adjuvant radiotherapy in the treatment of uterine carcinosarcoma according to the surgical intent: suggestion based on progression pattern
Uterine carcinosarcomas (UCS) are rare tumors. Consensus regarding therapeutic management in non-met...
To evaluate the use of adjuvant therapy after primary surgery for stage I–III uterine carcinosarcoma...
OBJECTIVE: Uterine carcinosarcoma is a rare, aggressive subtype of endometrial cancer. Treatment con...
Purpose: To evaluate the impact of postoperative radiotherapy (PORT) on patterns of failure and surv...
OBJECTIVE: Uterine carcinosarcomas (UCS) represent a rare but aggressive subset of endometrial cance...
Purpose The purpose of this study is to evaluate the clinicopathological characteristics, treatment,...
Uterine sarcomas (US) are a rare heterogeneous disease and their management is controversial, probab...
The uterine carcinosarcoma (UCS) is a rare entity with poor prognosis. Treatment of FIGO I-II UCS us...
Purpose: To analyze the prognostic factors for survivals and to evaluate the impact of postoperative...
The management of uterine sarcomas continues to present many difficulties. Primary surgery is the op...
The purpose of this study is to evaluate the clinicopathological characteristics, treatment, and pro...
Purpose: To investigate the prognostic factors and impact of adjuvant treatment on uterine carcinosa...
The purpose of this study is to evaluate the clinicopathological characteristics, treatment, and pro...
Objectives: To determine the clinical behavior and role of chemotherapy and surgical staging in the ...
Background: Uterine carcinosarcoma is rare neoplasm that mostly presents as metastatic disease. Stag...
Uterine carcinosarcomas (UCS) are rare tumors. Consensus regarding therapeutic management in non-met...
To evaluate the use of adjuvant therapy after primary surgery for stage I–III uterine carcinosarcoma...
OBJECTIVE: Uterine carcinosarcoma is a rare, aggressive subtype of endometrial cancer. Treatment con...
Purpose: To evaluate the impact of postoperative radiotherapy (PORT) on patterns of failure and surv...
OBJECTIVE: Uterine carcinosarcomas (UCS) represent a rare but aggressive subset of endometrial cance...
Purpose The purpose of this study is to evaluate the clinicopathological characteristics, treatment,...
Uterine sarcomas (US) are a rare heterogeneous disease and their management is controversial, probab...
The uterine carcinosarcoma (UCS) is a rare entity with poor prognosis. Treatment of FIGO I-II UCS us...
Purpose: To analyze the prognostic factors for survivals and to evaluate the impact of postoperative...
The management of uterine sarcomas continues to present many difficulties. Primary surgery is the op...
The purpose of this study is to evaluate the clinicopathological characteristics, treatment, and pro...
Purpose: To investigate the prognostic factors and impact of adjuvant treatment on uterine carcinosa...
The purpose of this study is to evaluate the clinicopathological characteristics, treatment, and pro...
Objectives: To determine the clinical behavior and role of chemotherapy and surgical staging in the ...
Background: Uterine carcinosarcoma is rare neoplasm that mostly presents as metastatic disease. Stag...
Uterine carcinosarcomas (UCS) are rare tumors. Consensus regarding therapeutic management in non-met...
To evaluate the use of adjuvant therapy after primary surgery for stage I–III uterine carcinosarcoma...
OBJECTIVE: Uterine carcinosarcoma is a rare, aggressive subtype of endometrial cancer. Treatment con...